BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
235 hedge funds and large institutions have $3.19B invested in Blueprint Medicines in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 79 increasing their positions, 86 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
235
Holders Change
-11
Holders Change %
-4.47%
% of All Funds
3.97%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
34
Increased
79
Reduced
86
Closed
39
Calls
$27.2M
Puts
$10.8M
Net Calls
+$16.3M
Net Calls Change
+$12M
Top Buyers
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$71.2M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$26.4M |
| 3 |
CC
Casdin Capital
New York
|
-$20.2M |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$18.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$18.5M |
